These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 13712338)

  • 1. [Problem of anticoagulant therapy in clinical neurology].
    HAUSMANOWA-PETRUSEWICZ I
    Neurol Neurochir Psychiatr Pol; 1960; 10():583-93. PubMed ID: 13712338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indication of anticoagulant therapy (T.A.C.) in neurology].
    WOLINETZ E; MAMO H
    Therapie; 1955; 10(6):880-4. PubMed ID: 13299244
    [No Abstract]   [Full Text] [Related]  

  • 3. Theory and rationale of anticoagulant therapy in occlusive cerebral vascular disease.
    MEYER JS
    Radiology; 1958 Jun; 70(6):815-24. PubMed ID: 13554847
    [No Abstract]   [Full Text] [Related]  

  • 4. Discussion on anticoagulant therapy.
    GROCH SN
    Neurology; 1961 Apr; 11(4)Pt 2():141-4. PubMed ID: 13708829
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulant therapy in cerebrovascular disease.
    MARSHALL J; SHAW DA
    Proc R Soc Med; 1959 Jul; 52(7):547-9. PubMed ID: 14421534
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulant therapy in acute cerebrovascular accidents. A controlled trial.
    MARSHALL J; SHAW DA
    Lancet; 1960 May; 1(7132):995-8. PubMed ID: 14421533
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticoagulant treatment of cerebral vascular accidents].
    DEBENEDETTI V; RAVERA M
    Atti Soc Ital Cardiol; 1959; 21(2)():Comunicazioni 120-1. PubMed ID: 13855697
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of oral anticoagulant therapy with whole blood prothrombin time devices: the future has begun.
    Tripodi A
    Thromb Haemost; 2000 Sep; 84(3):362-3. PubMed ID: 11019955
    [No Abstract]   [Full Text] [Related]  

  • 9. Different sensitivities of various thromboplastins to two blood collection systems for monitoring oral anticoagulant therapy.
    van den Besselaar AM; Bertina RM; van der Meer FJ; den Hartigh J
    Thromb Haemost; 1999 Jul; 82(1):153-4. PubMed ID: 10456474
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of contact-labile anticoagulant factors in thrombopenia following repeated blood transfusions].
    VANACORE C; PELLO F
    Prog Med (Napoli); 1958 Jul; 14(14):417-35. PubMed ID: 13591407
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticoagulants in cerebrovascular accidents].
    MACIAS CASTRO I
    Arch Hosp Univ; 1958; 10(2):193-8. PubMed ID: 13546010
    [No Abstract]   [Full Text] [Related]  

  • 12. [The action of cortisone on the function of the coagulant and anticoagulant systems of the blood].
    Seĭfulla RD
    Farmakol Toksikol; 1965; 28(3):333-6. PubMed ID: 5869651
    [No Abstract]   [Full Text] [Related]  

  • 13. [Laboratory monitoring of anticoagulant and thrombolysis treatment].
    Vilpo J
    Duodecim; 1986; 102(9):551-9. PubMed ID: 3720592
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory monitoring of oral anticoagulant therapy.
    Ginsberg JS; Hirsh J
    Hematol Pathol; 1989; 3(4):147-51. PubMed ID: 2697715
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of plasmas from donors under oral anticoagulant treatment for the expression of INR values.
    Moritz B; Lang H
    Haematologica; 1997; 82(5):630-3. PubMed ID: 9407737
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activated prothrombin complex preparations for the treatment of anticoagulant hemophilia. Preparation--method of operation--supply possibility].
    Wilms K; Sander W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):589-93. PubMed ID: 1714864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Attempted demonstration of a circulating anticoagulant in subjects treated with 5-phenyl-propyl-4-hydroxycoumarin].
    Bourgain RH; Kahn MJ
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):483-5. PubMed ID: 5367315
    [No Abstract]   [Full Text] [Related]  

  • 18. [Control of oral anticoagulant treatment using an automated method].
    García-Sanz R; Alberca I; Vázquez L; Hernández JM; Castellanos A; San Miguel JF
    Sangre (Barc); 1994 Apr; 39(2):95-8. PubMed ID: 8059301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible sensing of the anticoagulant heparin with protamine permselective membranes.
    Crespo GA; Afshar MG; Bakker E
    Angew Chem Int Ed Engl; 2012 Dec; 51(50):12575-8. PubMed ID: 23124959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
    Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
    Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.